Business Context and Reporting Period
This Form 8-K was filed by PharmAthene, Inc. on March 13, 2013. The report announces the financial and operating results for the fiscal year ended December 31, 2012. The filing includes a press release as Exhibit 99.1 containing the detailed results.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the year ended December 31, 2012.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It serves solely as a notification of the results announcement.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the attached press release (Exhibit 99.1).
- Confirm the company's cash position and burn rate as of December 31, 2012.
- Review the press release for any updates on clinical trial progress or regulatory milestones.
- Note that the information in this 8-K is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings.